AI assistant
Sending…
CStone Pharmaceuticals — Director's Dealing 2022
Jun 2, 2022
50715_rns_2022-06-02_f869c8c6-1d1f-4cef-926c-b81865dc082c.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
2 June 2022
Possible offer
Disclosure of dealings in the shares of Yankuang Energy Group Company Limited
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Descriptionof relevantsecurities | Nature of dealings | Purchas/ Sale | e | Totalnumberof shareinvolved | s | Totalamount paid/ received | Highest (H)prices paid/ received | Lowest (L)prices paid/ received | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CICC FinancialTrading Limited | 1 June2022 | Other typesof securities(e.g. equityswaps) | Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later than theclose of the morning trading session onthe trading day following the orginatingclient-driven dealing | Purchase | 30 | 0 | $11,992.1000 | $39.9737 | $39.9737 |
==> picture [71 x 43] intentionally omitted <==
Public Disclosure Form
| Ordinary | Closing / flattening / unwinding of | Sale | 300 | $12,007.0000 | $40.0300 | $40.0200 |
|---|---|---|---|---|---|---|
| shares | proprietary positions arising from | |||||
| unsolicited client-driven dealings. I | ||||||
| confirm this was done no later than the | ||||||
| close of the morning trading session on | ||||||
| the trading day following the orginating | ||||||
| client-driven dealing |
End
Note:
CICC Financial Trading Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.
CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.
The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.
More from CStone Pharmaceuticals
Transaction in Own Shares
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 27
Annual Report
2026
Apr 27
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 22
Share Issue/Capital Change
2026
Apr 22
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 20